Ergotamine-induced cardiovascular toxicity: mechanisms and clinical significance.
Rostoff
Pawel
P
Gajos
Grzegorz
G
Latacz
Pawel
P
Wozniczko
Milosz
M
Matysek
Jerzy
J
Piwowarska
Wieslawa
W
D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000503:physiopathology; D018360:Crystallography, X-Ray; D004878:Ergotamine / Q000737:chemistry / Q000506:poisoning* / Q000627:therapeutic use; D004881:Ergotism / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D014662:Vasoconstrictor Agents / Q000737:chemistry / Q000506:poisoning* / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D004878:Ergotamine